Table 3.
The relationship between B7-H3 in pancreatic cancer tissue and associated clinical pathological factors
| Pathologic parameter | Cases(N) | B7-H3 expression positive rate % | χ2 | P value |
|---|---|---|---|---|
| Male |
27 |
81.5 (22/27) |
0.536 |
0.464 |
| Female |
18 |
72.2 (13/18) |
||
| Age < 60 |
19 |
73.7 (14/19) |
0.319 |
0.572 |
| Age ≥60 |
26 |
80.8 (21/26) |
||
| Located in head |
37 |
81.1 (30/37) |
0.257 |
0.612 |
| Located in tail |
6 |
66.7 (4/6) |
||
| Whole pancreas cancer |
2 |
50 (1/2) |
||
| Size of primary carcinoma(<3 cm) |
30 |
86.7 (26/30) |
0.064 |
0.800 |
| Size of primary carcinoma(≥3 cm) |
15 |
60 (9/15) |
||
| Histodifferentiation(II) |
26 |
96.2 (25/26) |
12.161 |
0.002* |
| Histodifferentiation(III) |
7 |
57.2 (4/7) |
||
| Histodifferentiation(IV) |
12 |
50 (6/12) |
||
| Lymph nodes metastasis Negative |
20 |
65 (13/20) |
16.071 |
0.000* |
| Lymph nodes metastasis Positive |
25 |
88 (22/25) |
||
| pTNM stage I |
9 |
22.2 (2/9) |
23.377 | 0.000* |
| pTNM stage II |
11 |
72.7 (8/11) |
||
| pTNM stage III |
12 |
100 (12/12) |
||
| pTNM stage IV |
13 |
100 (13/13) |
||
| Normal tissue | 27 | 0 (0/27) |
*P < 0.01.